nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—hypertension—type 2 diabetes mellitus	0.346	1	CtDrD
Guanfacine—Phenacemide—Nateglinide—type 2 diabetes mellitus	0.136	1	CrCrCtD
Guanfacine—ADRA2A—type 2 diabetes mellitus	0.124	0.685	CbGaD
Guanfacine—CYP3A4—type 2 diabetes mellitus	0.0569	0.315	CbGaD
Guanfacine—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0228	0.0949	CbGbCtD
Guanfacine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0159	0.066	CbGbCtD
Guanfacine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0119	0.0494	CbGbCtD
Guanfacine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0116	0.0483	CbGbCtD
Guanfacine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0106	0.0442	CbGbCtD
Guanfacine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0101	0.042	CbGbCtD
Guanfacine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0101	0.042	CbGbCtD
Guanfacine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00987	0.0411	CbGbCtD
Guanfacine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00932	0.0388	CbGbCtD
Guanfacine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.009	0.0374	CbGbCtD
Guanfacine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0084	0.0349	CbGbCtD
Guanfacine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0084	0.0349	CbGbCtD
Guanfacine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00775	0.0322	CbGbCtD
Guanfacine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00758	0.0315	CbGbCtD
Guanfacine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00748	0.0311	CbGbCtD
Guanfacine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00684	0.0285	CbGbCtD
Guanfacine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00675	0.0281	CbGbCtD
Guanfacine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00636	0.0265	CbGbCtD
Guanfacine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00618	0.0257	CbGbCtD
Guanfacine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0061	0.0254	CbGbCtD
Guanfacine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0054	0.0225	CbGbCtD
Guanfacine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00517	0.0215	CbGbCtD
Guanfacine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00488	0.0203	CbGbCtD
Guanfacine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00473	0.0197	CbGbCtD
Guanfacine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0043	0.0179	CbGbCtD
Guanfacine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00393	0.0164	CbGbCtD
Guanfacine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0037	0.0154	CbGbCtD
Guanfacine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00355	0.0148	CbGbCtD
Guanfacine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00355	0.0148	CbGbCtD
Guanfacine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00335	0.014	CbGbCtD
Guanfacine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0025	0.0104	CbGbCtD
Guanfacine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00229	0.00951	CbGbCtD
Guanfacine—Guanabenz—ADRA2A—type 2 diabetes mellitus	0.000723	0.439	CrCbGaD
Guanfacine—Guanabenz—CYP1A2—type 2 diabetes mellitus	0.000502	0.305	CrCbGaD
Guanfacine—Diclofenac—CYP2E1—type 2 diabetes mellitus	0.000112	0.0682	CrCbGaD
Guanfacine—Diclofenac—CYP1A2—type 2 diabetes mellitus	0.000107	0.0649	CrCbGaD
Guanfacine—Diclofenac—CYP3A4—type 2 diabetes mellitus	7.06e-05	0.0429	CrCbGaD
Guanfacine—Diclofenac—PTGS2—type 2 diabetes mellitus	6.92e-05	0.042	CrCbGaD
Guanfacine—Somnolence—Gliclazide—type 2 diabetes mellitus	6.3e-05	0.000858	CcSEcCtD
Guanfacine—Hypertension—Metformin—type 2 diabetes mellitus	6.27e-05	0.000855	CcSEcCtD
Guanfacine—Nervousness—Losartan—type 2 diabetes mellitus	6.27e-05	0.000854	CcSEcCtD
Guanfacine—Abdominal pain—Glyburide—type 2 diabetes mellitus	6.24e-05	0.00085	CcSEcCtD
Guanfacine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	6.24e-05	0.00085	CcSEcCtD
Guanfacine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	6.22e-05	0.000847	CcSEcCtD
Guanfacine—Muscle spasms—Losartan—type 2 diabetes mellitus	6.21e-05	0.000845	CcSEcCtD
Guanfacine—Asthenia—Bromocriptine—type 2 diabetes mellitus	6.2e-05	0.000844	CcSEcCtD
Guanfacine—Myalgia—Metformin—type 2 diabetes mellitus	6.19e-05	0.000843	CcSEcCtD
Guanfacine—Chest pain—Metformin—type 2 diabetes mellitus	6.19e-05	0.000843	CcSEcCtD
Guanfacine—Malaise—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000842	CcSEcCtD
Guanfacine—Vertigo—Irbesartan—type 2 diabetes mellitus	6.16e-05	0.000839	CcSEcCtD
Guanfacine—Diclofenac—ALB—type 2 diabetes mellitus	6.16e-05	0.0375	CrCbGaD
Guanfacine—Headache—Pioglitazone—type 2 diabetes mellitus	6.16e-05	0.000839	CcSEcCtD
Guanfacine—Syncope—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000838	CcSEcCtD
Guanfacine—Visual impairment—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000835	CcSEcCtD
Guanfacine—Discomfort—Metformin—type 2 diabetes mellitus	6.11e-05	0.000833	CcSEcCtD
Guanfacine—Fatigue—Gliclazide—type 2 diabetes mellitus	6.11e-05	0.000833	CcSEcCtD
Guanfacine—Nausea—Glipizide—type 2 diabetes mellitus	6.09e-05	0.00083	CcSEcCtD
Guanfacine—Vomiting—Glimepiride—type 2 diabetes mellitus	6.09e-05	0.000829	CcSEcCtD
Guanfacine—Hypotension—Valsartan—type 2 diabetes mellitus	6.09e-05	0.000829	CcSEcCtD
Guanfacine—Vision blurred—Losartan—type 2 diabetes mellitus	6.08e-05	0.000829	CcSEcCtD
Guanfacine—Vomiting—Sitagliptin—type 2 diabetes mellitus	6.07e-05	0.000826	CcSEcCtD
Guanfacine—Constipation—Gliclazide—type 2 diabetes mellitus	6.06e-05	0.000826	CcSEcCtD
Guanfacine—Tremor—Losartan—type 2 diabetes mellitus	6.05e-05	0.000824	CcSEcCtD
Guanfacine—Rash—Glimepiride—type 2 diabetes mellitus	6.04e-05	0.000822	CcSEcCtD
Guanfacine—Dermatitis—Glimepiride—type 2 diabetes mellitus	6.03e-05	0.000821	CcSEcCtD
Guanfacine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	6.03e-05	0.000821	CcSEcCtD
Guanfacine—Rash—Sitagliptin—type 2 diabetes mellitus	6.02e-05	0.00082	CcSEcCtD
Guanfacine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	6.01e-05	0.000819	CcSEcCtD
Guanfacine—Headache—Glimepiride—type 2 diabetes mellitus	6e-05	0.000817	CcSEcCtD
Guanfacine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	5.99e-05	0.000816	CcSEcCtD
Guanfacine—Headache—Sitagliptin—type 2 diabetes mellitus	5.98e-05	0.000814	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	5.93e-05	0.000808	CcSEcCtD
Guanfacine—Agitation—Losartan—type 2 diabetes mellitus	5.93e-05	0.000808	CcSEcCtD
Guanfacine—Oedema—Metformin—type 2 diabetes mellitus	5.93e-05	0.000808	CcSEcCtD
Guanfacine—Tinnitus—Ramipril—type 2 diabetes mellitus	5.93e-05	0.000807	CcSEcCtD
Guanfacine—Hypertension—Irbesartan—type 2 diabetes mellitus	5.92e-05	0.000807	CcSEcCtD
Guanfacine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.91e-05	0.000805	CcSEcCtD
Guanfacine—Insomnia—Valsartan—type 2 diabetes mellitus	5.89e-05	0.000802	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.86e-05	0.000799	CcSEcCtD
Guanfacine—Paraesthesia—Valsartan—type 2 diabetes mellitus	5.85e-05	0.000797	CcSEcCtD
Guanfacine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	5.84e-05	0.000796	CcSEcCtD
Guanfacine—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000795	CcSEcCtD
Guanfacine—Myalgia—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000795	CcSEcCtD
Guanfacine—Chest pain—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000795	CcSEcCtD
Guanfacine—Shock—Metformin—type 2 diabetes mellitus	5.84e-05	0.000795	CcSEcCtD
Guanfacine—Insomnia—Orlistat—type 2 diabetes mellitus	5.82e-05	0.000793	CcSEcCtD
Guanfacine—Malaise—Losartan—type 2 diabetes mellitus	5.82e-05	0.000793	CcSEcCtD
Guanfacine—Anxiety—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000793	CcSEcCtD
Guanfacine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.82e-05	0.000792	CcSEcCtD
Guanfacine—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.81e-05	0.000791	CcSEcCtD
Guanfacine—Vertigo—Losartan—type 2 diabetes mellitus	5.8e-05	0.00079	CcSEcCtD
Guanfacine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.8e-05	0.00079	CcSEcCtD
Guanfacine—Somnolence—Valsartan—type 2 diabetes mellitus	5.79e-05	0.000789	CcSEcCtD
Guanfacine—Syncope—Losartan—type 2 diabetes mellitus	5.79e-05	0.000788	CcSEcCtD
Guanfacine—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.78e-05	0.000787	CcSEcCtD
Guanfacine—Discomfort—Irbesartan—type 2 diabetes mellitus	5.77e-05	0.000786	CcSEcCtD
Guanfacine—Immune system disorder—Ramipril—type 2 diabetes mellitus	5.74e-05	0.000782	CcSEcCtD
Guanfacine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	5.73e-05	0.000781	CcSEcCtD
Guanfacine—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.73e-05	0.000781	CcSEcCtD
Guanfacine—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.71e-05	0.000778	CcSEcCtD
Guanfacine—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.71e-05	0.000778	CcSEcCtD
Guanfacine—Palpitations—Losartan—type 2 diabetes mellitus	5.7e-05	0.000777	CcSEcCtD
Guanfacine—Nausea—Glimepiride—type 2 diabetes mellitus	5.69e-05	0.000775	CcSEcCtD
Guanfacine—Loss of consciousness—Losartan—type 2 diabetes mellitus	5.67e-05	0.000773	CcSEcCtD
Guanfacine—Nausea—Sitagliptin—type 2 diabetes mellitus	5.67e-05	0.000772	CcSEcCtD
Guanfacine—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.66e-05	0.000772	CcSEcCtD
Guanfacine—Asthenia—Glyburide—type 2 diabetes mellitus	5.66e-05	0.000772	CcSEcCtD
Guanfacine—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.66e-05	0.000771	CcSEcCtD
Guanfacine—Alopecia—Ramipril—type 2 diabetes mellitus	5.62e-05	0.000765	CcSEcCtD
Guanfacine—Fatigue—Valsartan—type 2 diabetes mellitus	5.62e-05	0.000765	CcSEcCtD
Guanfacine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.6e-05	0.000763	CcSEcCtD
Guanfacine—Oedema—Irbesartan—type 2 diabetes mellitus	5.6e-05	0.000762	CcSEcCtD
Guanfacine—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.59e-05	0.000762	CcSEcCtD
Guanfacine—Pruritus—Glyburide—type 2 diabetes mellitus	5.59e-05	0.000761	CcSEcCtD
Guanfacine—Constipation—Valsartan—type 2 diabetes mellitus	5.57e-05	0.000759	CcSEcCtD
Guanfacine—Fatigue—Orlistat—type 2 diabetes mellitus	5.55e-05	0.000756	CcSEcCtD
Guanfacine—Hypotension—Metformin—type 2 diabetes mellitus	5.54e-05	0.000755	CcSEcCtD
Guanfacine—Shock—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.00075	CcSEcCtD
Guanfacine—Chest pain—Losartan—type 2 diabetes mellitus	5.49e-05	0.000748	CcSEcCtD
Guanfacine—Arthralgia—Losartan—type 2 diabetes mellitus	5.49e-05	0.000748	CcSEcCtD
Guanfacine—Myalgia—Losartan—type 2 diabetes mellitus	5.49e-05	0.000748	CcSEcCtD
Guanfacine—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.49e-05	0.000748	CcSEcCtD
Guanfacine—Anxiety—Losartan—type 2 diabetes mellitus	5.48e-05	0.000746	CcSEcCtD
Guanfacine—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.46e-05	0.000744	CcSEcCtD
Guanfacine—Rash—Bromocriptine—type 2 diabetes mellitus	5.45e-05	0.000742	CcSEcCtD
Guanfacine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.44e-05	0.000741	CcSEcCtD
Guanfacine—Tension—Ramipril—type 2 diabetes mellitus	5.43e-05	0.00074	CcSEcCtD
Guanfacine—Discomfort—Losartan—type 2 diabetes mellitus	5.43e-05	0.00074	CcSEcCtD
Guanfacine—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000738	CcSEcCtD
Guanfacine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.41e-05	0.000737	CcSEcCtD
Guanfacine—Headache—Bromocriptine—type 2 diabetes mellitus	5.41e-05	0.000737	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.4e-05	0.000736	CcSEcCtD
Guanfacine—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.4e-05	0.000736	CcSEcCtD
Guanfacine—Nervousness—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000732	CcSEcCtD
Guanfacine—Dry mouth—Losartan—type 2 diabetes mellitus	5.37e-05	0.000732	CcSEcCtD
Guanfacine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.33e-05	0.000725	CcSEcCtD
Guanfacine—Paraesthesia—Metformin—type 2 diabetes mellitus	5.33e-05	0.000725	CcSEcCtD
Guanfacine—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000725	CcSEcCtD
Guanfacine—Confusional state—Losartan—type 2 diabetes mellitus	5.31e-05	0.000723	CcSEcCtD
Guanfacine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.3e-05	0.000722	CcSEcCtD
Guanfacine—Dyspnoea—Metformin—type 2 diabetes mellitus	5.29e-05	0.00072	CcSEcCtD
Guanfacine—Somnolence—Metformin—type 2 diabetes mellitus	5.27e-05	0.000718	CcSEcCtD
Guanfacine—Oedema—Losartan—type 2 diabetes mellitus	5.27e-05	0.000718	CcSEcCtD
Guanfacine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.26e-05	0.000717	CcSEcCtD
Guanfacine—Hypotension—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.000712	CcSEcCtD
Guanfacine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.22e-05	0.000711	CcSEcCtD
Guanfacine—Dyspepsia—Metformin—type 2 diabetes mellitus	5.22e-05	0.000711	CcSEcCtD
Guanfacine—Tremor—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000706	CcSEcCtD
Guanfacine—Shock—Losartan—type 2 diabetes mellitus	5.18e-05	0.000706	CcSEcCtD
Guanfacine—Decreased appetite—Metformin—type 2 diabetes mellitus	5.16e-05	0.000702	CcSEcCtD
Guanfacine—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.15e-05	0.000701	CcSEcCtD
Guanfacine—Tachycardia—Losartan—type 2 diabetes mellitus	5.14e-05	0.0007	CcSEcCtD
Guanfacine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000699	CcSEcCtD
Guanfacine—Nausea—Bromocriptine—type 2 diabetes mellitus	5.13e-05	0.000699	CcSEcCtD
Guanfacine—Fatigue—Metformin—type 2 diabetes mellitus	5.11e-05	0.000697	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.1e-05	0.000695	CcSEcCtD
Guanfacine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.09e-05	0.000694	CcSEcCtD
Guanfacine—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.09e-05	0.000693	CcSEcCtD
Guanfacine—Asthenia—Gliclazide—type 2 diabetes mellitus	5.09e-05	0.000693	CcSEcCtD
Guanfacine—Agitation—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000693	CcSEcCtD
Guanfacine—Constipation—Metformin—type 2 diabetes mellitus	5.07e-05	0.000691	CcSEcCtD
Guanfacine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.03e-05	0.000685	CcSEcCtD
Guanfacine—Vomiting—Glyburide—type 2 diabetes mellitus	5.02e-05	0.000684	CcSEcCtD
Guanfacine—Pruritus—Gliclazide—type 2 diabetes mellitus	5.02e-05	0.000683	CcSEcCtD
Guanfacine—Malaise—Ramipril—type 2 diabetes mellitus	4.99e-05	0.00068	CcSEcCtD
Guanfacine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.99e-05	0.00068	CcSEcCtD
Guanfacine—Rash—Glyburide—type 2 diabetes mellitus	4.98e-05	0.000678	CcSEcCtD
Guanfacine—Somnolence—Irbesartan—type 2 diabetes mellitus	4.98e-05	0.000678	CcSEcCtD
Guanfacine—Dermatitis—Glyburide—type 2 diabetes mellitus	4.97e-05	0.000677	CcSEcCtD
Guanfacine—Vertigo—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000677	CcSEcCtD
Guanfacine—Syncope—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000676	CcSEcCtD
Guanfacine—Headache—Glyburide—type 2 diabetes mellitus	4.95e-05	0.000674	CcSEcCtD
Guanfacine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000671	CcSEcCtD
Guanfacine—Hypotension—Losartan—type 2 diabetes mellitus	4.92e-05	0.00067	CcSEcCtD
Guanfacine—Palpitations—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000666	CcSEcCtD
Guanfacine—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.89e-05	0.000666	CcSEcCtD
Guanfacine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.87e-05	0.000663	CcSEcCtD
Guanfacine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000663	CcSEcCtD
Guanfacine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.85e-05	0.000661	CcSEcCtD
Guanfacine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.85e-05	0.000661	CcSEcCtD
Guanfacine—Fatigue—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.000657	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.8e-05	0.000654	CcSEcCtD
Guanfacine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.8e-05	0.000654	CcSEcCtD
Guanfacine—Convulsion—Ramipril—type 2 diabetes mellitus	4.79e-05	0.000653	CcSEcCtD
Guanfacine—Constipation—Irbesartan—type 2 diabetes mellitus	4.79e-05	0.000652	CcSEcCtD
Guanfacine—Insomnia—Losartan—type 2 diabetes mellitus	4.76e-05	0.000649	CcSEcCtD
Guanfacine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.74e-05	0.000646	CcSEcCtD
Guanfacine—Paraesthesia—Losartan—type 2 diabetes mellitus	4.73e-05	0.000644	CcSEcCtD
Guanfacine—Myalgia—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000642	CcSEcCtD
Guanfacine—Chest pain—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000642	CcSEcCtD
Guanfacine—Arthralgia—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000642	CcSEcCtD
Guanfacine—Dyspnoea—Losartan—type 2 diabetes mellitus	4.7e-05	0.00064	CcSEcCtD
Guanfacine—Anxiety—Ramipril—type 2 diabetes mellitus	4.7e-05	0.00064	CcSEcCtD
Guanfacine—Nausea—Glyburide—type 2 diabetes mellitus	4.69e-05	0.000639	CcSEcCtD
Guanfacine—Abdominal pain—Metformin—type 2 diabetes mellitus	4.69e-05	0.000639	CcSEcCtD
Guanfacine—Dizziness—Gliclazide—type 2 diabetes mellitus	4.69e-05	0.000639	CcSEcCtD
Guanfacine—Somnolence—Losartan—type 2 diabetes mellitus	4.68e-05	0.000638	CcSEcCtD
Guanfacine—Asthenia—Valsartan—type 2 diabetes mellitus	4.67e-05	0.000637	CcSEcCtD
Guanfacine—Discomfort—Ramipril—type 2 diabetes mellitus	4.65e-05	0.000634	CcSEcCtD
Guanfacine—Dyspepsia—Losartan—type 2 diabetes mellitus	4.64e-05	0.000632	CcSEcCtD
Guanfacine—Asthenia—Orlistat—type 2 diabetes mellitus	4.62e-05	0.000629	CcSEcCtD
Guanfacine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.61e-05	0.000628	CcSEcCtD
Guanfacine—Pruritus—Valsartan—type 2 diabetes mellitus	4.61e-05	0.000628	CcSEcCtD
Guanfacine—Dry mouth—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000628	CcSEcCtD
Guanfacine—Decreased appetite—Losartan—type 2 diabetes mellitus	4.58e-05	0.000624	CcSEcCtD
Guanfacine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.58e-05	0.000623	CcSEcCtD
Guanfacine—Confusional state—Ramipril—type 2 diabetes mellitus	4.55e-05	0.00062	CcSEcCtD
Guanfacine—Pruritus—Orlistat—type 2 diabetes mellitus	4.55e-05	0.00062	CcSEcCtD
Guanfacine—Fatigue—Losartan—type 2 diabetes mellitus	4.54e-05	0.000619	CcSEcCtD
Guanfacine—Oedema—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000615	CcSEcCtD
Guanfacine—Vomiting—Gliclazide—type 2 diabetes mellitus	4.51e-05	0.000614	CcSEcCtD
Guanfacine—Constipation—Losartan—type 2 diabetes mellitus	4.5e-05	0.000614	CcSEcCtD
Guanfacine—Rash—Gliclazide—type 2 diabetes mellitus	4.47e-05	0.000609	CcSEcCtD
Guanfacine—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.47e-05	0.000608	CcSEcCtD
Guanfacine—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.46e-05	0.000607	CcSEcCtD
Guanfacine—Shock—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000605	CcSEcCtD
Guanfacine—Headache—Gliclazide—type 2 diabetes mellitus	4.44e-05	0.000605	CcSEcCtD
Guanfacine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000603	CcSEcCtD
Guanfacine—Tachycardia—Ramipril—type 2 diabetes mellitus	4.41e-05	0.0006	CcSEcCtD
Guanfacine—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.4e-05	0.0006	CcSEcCtD
Guanfacine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000595	CcSEcCtD
Guanfacine—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.34e-05	0.000591	CcSEcCtD
Guanfacine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.31e-05	0.000587	CcSEcCtD
Guanfacine—Dizziness—Valsartan—type 2 diabetes mellitus	4.31e-05	0.000587	CcSEcCtD
Guanfacine—Dizziness—Orlistat—type 2 diabetes mellitus	4.26e-05	0.00058	CcSEcCtD
Guanfacine—Asthenia—Metformin—type 2 diabetes mellitus	4.26e-05	0.00058	CcSEcCtD
Guanfacine—Hypotension—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000575	CcSEcCtD
Guanfacine—Nausea—Gliclazide—type 2 diabetes mellitus	4.21e-05	0.000574	CcSEcCtD
Guanfacine—Pruritus—Metformin—type 2 diabetes mellitus	4.2e-05	0.000572	CcSEcCtD
Guanfacine—Abdominal pain—Losartan—type 2 diabetes mellitus	4.16e-05	0.000567	CcSEcCtD
Guanfacine—Vomiting—Valsartan—type 2 diabetes mellitus	4.14e-05	0.000564	CcSEcCtD
Guanfacine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.12e-05	0.000562	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000561	CcSEcCtD
Guanfacine—Rash—Valsartan—type 2 diabetes mellitus	4.11e-05	0.000559	CcSEcCtD
Guanfacine—Dermatitis—Valsartan—type 2 diabetes mellitus	4.1e-05	0.000559	CcSEcCtD
Guanfacine—Vomiting—Orlistat—type 2 diabetes mellitus	4.09e-05	0.000557	CcSEcCtD
Guanfacine—Insomnia—Ramipril—type 2 diabetes mellitus	4.09e-05	0.000556	CcSEcCtD
Guanfacine—Headache—Valsartan—type 2 diabetes mellitus	4.08e-05	0.000556	CcSEcCtD
Guanfacine—Diarrhoea—Metformin—type 2 diabetes mellitus	4.06e-05	0.000553	CcSEcCtD
Guanfacine—Rash—Orlistat—type 2 diabetes mellitus	4.06e-05	0.000553	CcSEcCtD
Guanfacine—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.06e-05	0.000552	CcSEcCtD
Guanfacine—Dermatitis—Orlistat—type 2 diabetes mellitus	4.05e-05	0.000552	CcSEcCtD
Guanfacine—Headache—Orlistat—type 2 diabetes mellitus	4.03e-05	0.000549	CcSEcCtD
Guanfacine—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000549	CcSEcCtD
Guanfacine—Asthenia—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.000547	CcSEcCtD
Guanfacine—Somnolence—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000547	CcSEcCtD
Guanfacine—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000542	CcSEcCtD
Guanfacine—Pruritus—Irbesartan—type 2 diabetes mellitus	3.96e-05	0.000539	CcSEcCtD
Guanfacine—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.93e-05	0.000535	CcSEcCtD
Guanfacine—Dizziness—Metformin—type 2 diabetes mellitus	3.92e-05	0.000534	CcSEcCtD
Guanfacine—Fatigue—Ramipril—type 2 diabetes mellitus	3.89e-05	0.00053	CcSEcCtD
Guanfacine—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.88e-05	0.000529	CcSEcCtD
Guanfacine—Nausea—Valsartan—type 2 diabetes mellitus	3.87e-05	0.000527	CcSEcCtD
Guanfacine—Constipation—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000526	CcSEcCtD
Guanfacine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.83e-05	0.000522	CcSEcCtD
Guanfacine—Nausea—Orlistat—type 2 diabetes mellitus	3.82e-05	0.000521	CcSEcCtD
Guanfacine—Asthenia—Losartan—type 2 diabetes mellitus	3.78e-05	0.000515	CcSEcCtD
Guanfacine—Vomiting—Metformin—type 2 diabetes mellitus	3.77e-05	0.000514	CcSEcCtD
Guanfacine—Rash—Metformin—type 2 diabetes mellitus	3.74e-05	0.000509	CcSEcCtD
Guanfacine—Dermatitis—Metformin—type 2 diabetes mellitus	3.74e-05	0.000509	CcSEcCtD
Guanfacine—Pruritus—Losartan—type 2 diabetes mellitus	3.73e-05	0.000508	CcSEcCtD
Guanfacine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000507	CcSEcCtD
Guanfacine—Headache—Metformin—type 2 diabetes mellitus	3.72e-05	0.000506	CcSEcCtD
Guanfacine—Dizziness—Irbesartan—type 2 diabetes mellitus	3.7e-05	0.000504	CcSEcCtD
Guanfacine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000503	CcSEcCtD
Guanfacine—Diarrhoea—Losartan—type 2 diabetes mellitus	3.6e-05	0.000491	CcSEcCtD
Guanfacine—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000486	CcSEcCtD
Guanfacine—Vomiting—Irbesartan—type 2 diabetes mellitus	3.56e-05	0.000485	CcSEcCtD
Guanfacine—Rash—Irbesartan—type 2 diabetes mellitus	3.53e-05	0.000481	CcSEcCtD
Guanfacine—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.53e-05	0.00048	CcSEcCtD
Guanfacine—Nausea—Metformin—type 2 diabetes mellitus	3.52e-05	0.00048	CcSEcCtD
Guanfacine—Headache—Irbesartan—type 2 diabetes mellitus	3.51e-05	0.000478	CcSEcCtD
Guanfacine—Dizziness—Losartan—type 2 diabetes mellitus	3.48e-05	0.000474	CcSEcCtD
Guanfacine—Vomiting—Losartan—type 2 diabetes mellitus	3.35e-05	0.000456	CcSEcCtD
Guanfacine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000453	CcSEcCtD
Guanfacine—Nausea—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.000453	CcSEcCtD
Guanfacine—Rash—Losartan—type 2 diabetes mellitus	3.32e-05	0.000452	CcSEcCtD
Guanfacine—Dermatitis—Losartan—type 2 diabetes mellitus	3.32e-05	0.000452	CcSEcCtD
Guanfacine—Headache—Losartan—type 2 diabetes mellitus	3.3e-05	0.00045	CcSEcCtD
Guanfacine—Asthenia—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000441	CcSEcCtD
Guanfacine—Pruritus—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000435	CcSEcCtD
Guanfacine—Nausea—Losartan—type 2 diabetes mellitus	3.13e-05	0.000426	CcSEcCtD
Guanfacine—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000421	CcSEcCtD
Guanfacine—Dizziness—Ramipril—type 2 diabetes mellitus	2.99e-05	0.000407	CcSEcCtD
Guanfacine—Vomiting—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000391	CcSEcCtD
Guanfacine—Rash—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000388	CcSEcCtD
Guanfacine—Dermatitis—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000388	CcSEcCtD
Guanfacine—Headache—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000385	CcSEcCtD
Guanfacine—Nausea—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000365	CcSEcCtD
Guanfacine—ADRA2A—Signaling Pathways—GCG—type 2 diabetes mellitus	3.37e-06	0.000152	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	3.37e-06	0.000151	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.35e-06	0.000151	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	3.35e-06	0.000151	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	3.35e-06	0.000151	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	3.35e-06	0.000151	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	3.33e-06	0.00015	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	3.33e-06	0.000149	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.32e-06	0.000149	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOB—type 2 diabetes mellitus	3.32e-06	0.000149	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.31e-06	0.000149	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.31e-06	0.000148	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	3.3e-06	0.000148	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	3.3e-06	0.000148	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	3.3e-06	0.000148	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.27e-06	0.000147	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	3.27e-06	0.000147	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	3.27e-06	0.000147	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	3.27e-06	0.000147	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	3.27e-06	0.000147	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TGFB1—type 2 diabetes mellitus	3.24e-06	0.000146	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	3.24e-06	0.000145	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	3.23e-06	0.000145	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GSTM1—type 2 diabetes mellitus	3.23e-06	0.000145	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.22e-06	0.000144	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	3.21e-06	0.000144	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—LPL—type 2 diabetes mellitus	3.17e-06	0.000142	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.16e-06	0.000142	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.16e-06	0.000142	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—C3—type 2 diabetes mellitus	3.14e-06	0.000141	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	3.14e-06	0.000141	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.1e-06	0.000139	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ADCY5—type 2 diabetes mellitus	3.1e-06	0.000139	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.1e-06	0.000139	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GPX1—type 2 diabetes mellitus	3.09e-06	0.000139	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.08e-06	0.000138	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	3.02e-06	0.000135	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.02e-06	0.000135	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CD36—type 2 diabetes mellitus	3.01e-06	0.000135	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	3.01e-06	0.000135	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	3.01e-06	0.000135	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	3.01e-06	0.000135	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3e-06	0.000135	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.99e-06	0.000134	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AGT—type 2 diabetes mellitus	2.99e-06	0.000134	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	2.98e-06	0.000134	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	2.98e-06	0.000134	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—AKT1—type 2 diabetes mellitus	2.97e-06	0.000133	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPP2CA—type 2 diabetes mellitus	2.97e-06	0.000133	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	2.95e-06	0.000133	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.94e-06	0.000132	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.94e-06	0.000132	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LEP—type 2 diabetes mellitus	2.93e-06	0.000131	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOE—type 2 diabetes mellitus	2.93e-06	0.000131	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	2.92e-06	0.000131	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.91e-06	0.000131	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	2.91e-06	0.000131	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.89e-06	0.00013	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.89e-06	0.00013	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.88e-06	0.00013	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.88e-06	0.000129	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AVP—type 2 diabetes mellitus	2.87e-06	0.000129	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.87e-06	0.000129	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	2.86e-06	0.000129	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	2.86e-06	0.000128	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	2.86e-06	0.000128	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.86e-06	0.000128	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—MTHFR—type 2 diabetes mellitus	2.85e-06	0.000128	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.84e-06	0.000128	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.81e-06	0.000126	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARA—type 2 diabetes mellitus	2.8e-06	0.000126	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.78e-06	0.000125	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.78e-06	0.000125	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.78e-06	0.000125	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.78e-06	0.000125	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOB—type 2 diabetes mellitus	2.77e-06	0.000125	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.76e-06	0.000124	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.76e-06	0.000124	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.75e-06	0.000123	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.73e-06	0.000123	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	2.72e-06	0.000122	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	2.72e-06	0.000122	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AGT—type 2 diabetes mellitus	2.71e-06	0.000122	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.67e-06	0.00012	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CALM1—type 2 diabetes mellitus	2.66e-06	0.00012	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOE—type 2 diabetes mellitus	2.65e-06	0.000119	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.65e-06	0.000119	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	2.65e-06	0.000119	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.64e-06	0.000118	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOA1—type 2 diabetes mellitus	2.62e-06	0.000118	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.61e-06	0.000117	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.61e-06	0.000117	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	2.61e-06	0.000117	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.59e-06	0.000116	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—INS—type 2 diabetes mellitus	2.5e-06	0.000112	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.48e-06	0.000112	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.48e-06	0.000111	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.46e-06	0.000111	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.46e-06	0.000111	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.46e-06	0.00011	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.45e-06	0.00011	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.44e-06	0.00011	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.42e-06	0.000109	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.42e-06	0.000109	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.42e-06	0.000108	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.41e-06	0.000108	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	2.38e-06	0.000107	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.35e-06	0.000105	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.32e-06	0.000104	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	2.31e-06	0.000104	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.3e-06	0.000103	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.29e-06	0.000103	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.27e-06	0.000102	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.27e-06	0.000102	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.27e-06	0.000102	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.27e-06	0.000102	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	2.27e-06	0.000102	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.27e-06	0.000102	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	2.25e-06	0.000101	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.25e-06	0.000101	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.25e-06	0.000101	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.24e-06	0.000101	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.24e-06	0.0001	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.23e-06	0.0001	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.22e-06	9.99e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.22e-06	9.97e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.22e-06	9.97e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.21e-06	9.93e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.21e-06	9.93e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.21e-06	9.93e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.21e-06	9.91e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.2e-06	9.86e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.2e-06	9.86e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.19e-06	9.85e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.19e-06	9.84e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.19e-06	9.84e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.19e-06	9.83e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.16e-06	9.69e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.14e-06	9.62e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.13e-06	9.58e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.13e-06	9.57e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.1e-06	9.45e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.09e-06	9.4e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.08e-06	9.36e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	2.08e-06	9.33e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	2.06e-06	9.26e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.05e-06	9.18e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.02e-06	9.07e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2e-06	8.99e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2e-06	8.96e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.99e-06	8.93e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.99e-06	8.93e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.98e-06	8.9e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.98e-06	8.9e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.98e-06	8.9e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.98e-06	8.9e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.98e-06	8.89e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.95e-06	8.74e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.94e-06	8.73e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.93e-06	8.66e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.92e-06	8.62e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.92e-06	8.62e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.9e-06	8.51e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.89e-06	8.48e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.89e-06	8.47e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.88e-06	8.44e-05	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.88e-06	8.43e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.87e-06	8.38e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.86e-06	8.35e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.86e-06	8.35e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.85e-06	8.3e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.84e-06	8.27e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.83e-06	8.23e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.83e-06	8.23e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.82e-06	8.19e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.82e-06	8.17e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.81e-06	8.14e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.81e-06	8.11e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.79e-06	8.05e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.79e-06	8.05e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.76e-06	7.89e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.75e-06	7.86e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.74e-06	7.82e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.74e-06	7.81e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.72e-06	7.73e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.72e-06	7.72e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.72e-06	7.72e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.71e-06	7.7e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.71e-06	7.66e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.7e-06	7.61e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.66e-06	7.47e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.66e-06	7.47e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.64e-06	7.35e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.62e-06	7.28e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.61e-06	7.21e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.58e-06	7.09e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.57e-06	7.03e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.49e-06	6.71e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.48e-06	6.65e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.48e-06	6.65e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.48e-06	6.62e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.47e-06	6.61e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.46e-06	6.58e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.46e-06	6.53e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.45e-06	6.51e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.42e-06	6.4e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.42e-06	6.38e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.41e-06	6.34e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.41e-06	6.34e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.41e-06	6.33e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.41e-06	6.33e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.4e-06	6.3e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.37e-06	6.17e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.35e-06	6.06e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.34e-06	6.03e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.33e-06	5.99e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.32e-06	5.93e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.32e-06	5.93e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.32e-06	5.91e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.29e-06	5.81e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.29e-06	5.79e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.28e-06	5.77e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.28e-06	5.77e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.28e-06	5.76e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.27e-06	5.68e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.23e-06	5.52e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.21e-06	5.45e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.2e-06	5.38e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.19e-06	5.35e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.17e-06	5.28e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.15e-06	5.18e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.13e-06	5.1e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.13e-06	5.08e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.12e-06	5.02e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.1e-06	4.94e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.09e-06	4.9e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.08e-06	4.84e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.01e-06	4.52e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	9.85e-07	4.42e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.66e-07	4.34e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	9.14e-07	4.1e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	8.86e-07	3.98e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.47e-07	3.8e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.47e-07	3.8e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.29e-07	3.72e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.75e-07	3.48e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.64e-07	3.43e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	6.48e-07	2.91e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	5.91e-07	2.65e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.89e-07	1.75e-05	CbGpPWpGaD
